Publikationen, an denen er mitarbeitet Alfredo José Lucendo Villarín (6)

2023

  1. Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  2. Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease

    Biomedicine and Pharmacotherapy, Vol. 159

2021

  1. Comparison of a new rapid method for determination of serum anti-adalimumab and anti-infliximab antibodies with two established ELISA kits

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 198

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

  2. Comparison of a new rapid method for the determination of adalimumab serum levels with two established ELISA kits

    Clinical Chemistry and Laboratory Medicine, Vol. 57, Núm. 12, pp. 1906-1914

  3. Genetic predictors of long-term response and trough levels of infliximab in crohn's disease

    Pharmacological Research, Vol. 149